Aloe Vera

Aloe vera may decrease intestinal warfarin absorption and increase renal warfarin clearance (anthranoid-mediated GI acceleration), while simultaneously aloe's salicylate content exerts antiplatelet effects. A case report documents INR reduction with warfarin and home-made aloe preparation. Complex interaction with potential for either increased or decreased anticoagulation effect depending on preparation and dose.

Monitor INR closely when patients on warfarin use oral aloe preparations. INR may increase or decrease unpredictably. Topical aloe gel is safe with warfarin. Oral aloe latex (anthraquinone-containing) is of greater concern. Advise patients to disclose aloe use and avoid self-medication changes.

Oral aloe vera latex (anthraquinone-containing) acts as a stimulant laxative causing diarrhea and potassium loss (hypokalemia). Hypokalemia dramatically sensitizes the myocardium to digoxin toxicity: digitalis glycosides compete with potassium for cardiac Na+/K+ ATPase binding, so low potassium greatly increases digoxin toxicity risk (arrhythmias, heart block, ventricular fibrillation).

Do NOT combine oral aloe vera latex/anthraquinone preparations with digoxin. Monitor serum potassium levels if aloe vera use is identified in digoxin-treated patients. Signs of digoxin toxicity include nausea, visual disturbance, bradycardia, and arrhythmias. Topical aloe gel is safe with digoxin.

Aloe vera gel demonstrates hypoglycemic activity in clinical studies involving type 2 diabetes patients, attributed to acemannan polysaccharides and phytosterols that may improve insulin sensitivity and reduce hepatic glucose production. Combined with pharmaceutical antidiabetics, additive glucose-lowering effects can cause hypoglycemia, particularly with insulin and sulfonylureas.

Monitor blood glucose closely when patients on antidiabetic therapy use oral aloe vera gel. Watch for hypoglycemia symptoms especially if insulin dose is unchanged. Oral aloe gel is the form with documented glucose-lowering effects; topical gel does not have this interaction.

Oral aloe latex (anthraquinone fraction) is a stimulant laxative causing significant potassium loss via the colon. Combined with loop or thiazide diuretics that also deplete potassium, severe hypokalemia can result, leading to cardiac arrhythmias, muscle weakness, and metabolic alkalosis. The combination of two potassium-depleting mechanisms is clinically dangerous.

Avoid oral aloe latex with diuretic therapy. If aloe gel (anthraquinone-free) is used, risk is substantially lower but electrolyte monitoring is still prudent. Monitor serum potassium, especially in patients on digoxin (triple risk: aloe + diuretic + digoxin = severe hypokalemia risk). Topical aloe is safe.

Aloe vera contains salicylates that inhibit platelet aggregation via thromboxane A2 pathway inhibition. Sevoflurane also inhibits platelet aggregation and has anticoagulant properties. A published case report documents massive bleeding during surgery in a patient who used aloe vera, attributed to additive antiplatelet effects of these two agents.

Stop oral aloe vera preparations at least 2 weeks before elective surgery. Inform anesthesiologists of aloe vera use. In emergency surgery, be prepared for potential excessive bleeding. Topical aloe gel on intact skin distant from the surgical site is generally safe perioperatively.

Aloe vera anthraquinones (aloin, aloe-emodin) may induce CYP3A4 at high doses in vitro. Diarrheal effects from aloe latex also reduce absorption and transit time of co-administered medications. Combined effects may reduce plasma concentrations of CYP3A4-metabolized drugs and decrease their therapeutic efficacy.

Monitor CYP3A4-sensitive drug levels (cyclosporine, tacrolimus) if aloe latex products are used. Separate oral medication timing from aloe preparations by at least 2 hours. Transplant patients on calcineurin inhibitors should avoid oral aloe vera latex preparations due to unpredictable drug level changes.